TacomaMan Posted October 31, 2018 Share Posted October 31, 2018 Hello all, I just recently registered for this board. So, I am trying to find my way around this. Pardon me, if SPHS has already been discussed or is being discussed. I am trying to inquire whether anyone holds a position in Sophiris Bio (Nasdaq ticker SPHS)? If so, I am wondering what your thoughts are respective its current share price. I realize that Ph2B final patient results are due late Q4 of 2018. I hold Randall Woods and is staff as very knowledgeable, but am concerned whether dilution may be on the horizon, particularly if he chooses to progress into Phase 3 for PC and possibly into another Phase 3 for BPH? Appreciate any feedback. I own and have been holding a position for nearly 3 years. Thanks again. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now